AFWM
REGN icon

Abich Financial Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Abich Financial Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.25K Buy
+4
New +$2.26K ﹤0.01% 570
2024
Q1 		– Sell
-8
Closed -$7.03K – 610
2023
Q4 		$7.03K Buy
+8
New +$6.59K 0.01% 231

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abich Financial Wealth Management's REGN Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2025: 4 shares worth $2.25K. The stake represents ﹤0.01% of the portfolio and ranks #570 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in REGN as recently as Q4 2023.

Abich Financial Wealth Management first reported a position in REGN in Q4 2023 and has held it in 2 quarters since. The position peaked at $7.03K in Q4 2023. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Abich Financial Wealth Management held 4 shares of Regeneron Pharmaceuticals worth $2.25K as of Q3 2025.
  • Regeneron Pharmaceuticals was a new Abich Financial Wealth Management position in Q3 2025.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Abich Financial Wealth Management's portfolio in Q3 2025, its #570 holding.
  • Abich Financial Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • Abich Financial Wealth Management's Regeneron Pharmaceuticals position peaked at $7.03K in Q4 2023.
  • 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.